Waterfront Wealth’s Biogen BIIB Stock Holding History

Waterfront Wealth’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$471K	Sell	1,939 -4	-0.2%	-$848	0.08%	223
2026 Q2	$387K	Sell	1,943 -804	-29%	-$154K	0.06%	236
2026 Q1	$504K	Sell	2,747 -22	-0.8%	-$4.05K	0.09%	202
2025 Q4	$474K	Buy	2,769 +38	+1%	+$6.21K	0.09%	199
2025 Q3	$402K	Buy	+2,731	New	+$369K	0.08%	204
2025 Q2	–	Sell	-1,593	Closed	-$218K	–	263
2025 Q1	$218K	Buy	+1,593	New	+$228K	0.05%	244
2021 Q4	–	Sell	-760	Closed	-$215K	–	221
2021 Q3	$215K	Sell	760 -15	-2%	-$4.92K	0.1%	165
2021 Q2	$268K	Sell	775 -7	-0.9%	-$2.12K	0.13%	146
2021 Q1	$218K	Buy	+782	New	+$211K	0.11%	156

Other funds holding BIIB

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return

Waterfront Wealth's BIIB Position: Q3 2026 in Review

Waterfront Wealth reduced its Biogen (BIIB) stake by 0.21% in Q3 2026, selling an estimated $848 and leaving 1,939 shares worth $471K. The position accounts for 0.08% of the portfolio, ranked #223.

Waterfront Wealth first reported a position in BIIB in Q1 2021 and has held it in 9 quarters since. The position peaked at $504K in Q1 2026. 536 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.

Waterfront Wealth held 1,939 shares of Biogen worth $471K as of Q3 2026.
Waterfront Wealth sold 4 Biogen shares in Q3 2026, an estimated $848.
Biogen made up 0.08% of Waterfront Wealth's portfolio in Q3 2026, its #223 holding.
Waterfront Wealth first reported a position in Biogen in Q1 2021 and has held it in 9 quarters since.
Waterfront Wealth's Biogen position peaked at $504K in Q1 2026.
536 funds tracked by Wall St. Rank held Biogen as of Q3 2026.

Based on Waterfront Wealth's 13F filing for Q3 2026, filed 3 Nov 2026.